echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Indiana University cancer researchers receive $2.5 million in funding to develop treatments for lung cancer

    Indiana University cancer researchers receive $2.5 million in funding to develop treatments for lung cancer

    • Last Update: 2021-09-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A researcher from the Indiana University Melvin and Brenn Simon Comprehensive Cancer Center received a five-year, 2.


    The research led by Dr.


    The human body repairs DNA damage caused by the sun's ultraviolet rays, the toxins in the air, and the chemicals in cigarettes every day


    Turchi said: "The new therapies we are developing will treat patients who usually have limited treatment options, including lung cancer caused by smoking


    Lung cancer is the leading cause of cancer deaths in men and women, accounting for more than 20% of all cancer deaths


    Turchi said: "When we can inhibit the binding of replication protein A to single-stranded DNA under replication pressure, we can induce a large number of cell deaths-this is for cancer, which gives us a window of treatment


    The RPA inhibitor developed by IU researchers targets cancer through a mechanism different from other cancer treatments


    In addition to the application of lung cancer, Turchi's research team is also exploring RPA inhibitors for the treatment of ovarian cancer


    Turchi's laboratory is currently working to transfer research results from the cancer research laboratory to clinical patients, based on decades of research on these pathways


    Turchi said: "Our current work is not so much discovery, as it is implementation and translation work driven by clinical possibilities


    For this research, Turchi and Cancer Center researchers established a new collaboration at the core research facility: Jun Wan, Ph.


    "The complementary expertise of many cancer center researchers will allow us to answer some really important questions and ultimately affect the lives of patients," he said




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.